Literature DB >> 3267696

Effects of synthetic polycations on leucine incorporation, lactate dehydrogenase release, and morphology of human umbilical vein endothelial cells.

D M Morgan1, J Clover, J D Pearson.   

Abstract

Naturally occurring cationic proteins secreted by human granulocytes have pro-inflammatory effects including induction of increased vascular permeability and oedema, which are likely to be mediated by damage to vascular endothelium. Synthetic cationic polyamino acids have been shown to exert similar inflammatory effects in vivo. We have therefore used a range of synthetic polycationic amino acids to investigate the characteristics required to cause endothelial cell damage, assessed by in vitro inhibition of leucine incorporation into macromolecules by human umbilical vein endothelial cells (HUVEC) in culture. Exposure of HUVEC to 20 nM-2 microM cationic polypeptides of similar Mr(av) (approximately 40,000) in the presence of 20% serum produced a dose-dependent inhibition of [3H]leucine incorporation by polymers of ornithine, arginine or lysine. Similar results were obtained using [3H]thymidine. Neutral or anionic polypeptides of similar Mr were without effect. The molar potency of polylysines increased over the range Mr 40,000-120,000, while polylysines of Mr(av) less than 25,000 had no effect. In the absence of serum, inhibition occurred more rapidly and at lower doses. Inhibition of leucine and thymidine incorporation was time-dependent, e.g. exposure to 800 nM-polylysine, Mr(av) 90,000, led to progressively increasing inhibition that was complete after 24 h exposure, and was irreversible. The effects of polycations could not be blocked by pretreatment of the cells with polyanions. Precoating of the culture surface with polylysines had no effect on leucine incorporation by HUVEC or their subsequent response to polylysines in solution. Exposure to the peptide Arg-Gly-Asp-Ser inhibited incorporation by 30% but did not increase susceptibility to polylysine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3267696     DOI: 10.1242/jcs.91.2.231

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

Review 1.  Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility.

Authors:  You-Xiong Wang; John L Robertson; William B Spillman; Richard O Claus
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Effects of X-ray contrast media and radiation on human vascular endothelial cells in vitro.

Authors:  D M Morgan; M A Bettmann
Journal:  Cardiovasc Intervent Radiol       Date:  1989 May-Jun       Impact factor: 2.740

Review 3.  Future nanomedicine for the diagnosis and treatment of osteoarthritis.

Authors:  Lauren R Eichaker; Hongsik Cho; Craig L Duvall; Thomas A Werfel; Karen A Hasty
Journal:  Nanomedicine (Lond)       Date:  2014-07       Impact factor: 5.307

4.  Cytotoxicity of free versus multilayered polyelectrolytes.

Authors:  Jessica S Martinez; Thomas C S Keller; Joseph B Schlenoff
Journal:  Biomacromolecules       Date:  2011-10-25       Impact factor: 6.988

5.  Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.

Authors:  G Degols; J P Leonetti; N Mechti; B Lebleu
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

6.  L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.

Authors:  H H Schmidt; S E Baeblich; B C Zernikow; M M Klein; E Böhme
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

7.  Rat mesangial cell lysis in vitro is induced by cationic polypeptides.

Authors:  J A Broestl; S N Emancipator
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  A comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cells.

Authors:  Shinji Toki; Reed A Omary; Kevin Wilson; John C Gore; R Stokes Peebles; Wellington Pham
Journal:  Nanomedicine       Date:  2013-06-06       Impact factor: 5.307

9.  Nanoparticles - known and unknown health risks.

Authors:  Peter Hm Hoet; Irene Brüske-Hohlfeld; Oleg V Salata
Journal:  J Nanobiotechnology       Date:  2004-12-08       Impact factor: 10.435

10.  Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.

Authors:  Jing Li; Ana-Maria Lepadatu; Yu Zhu; Marius Ciobanu; Yan Wang; Simona C Asaftei; David Oupický
Journal:  Bioconjug Chem       Date:  2014-05-12       Impact factor: 4.774

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.